Clinical molecular imaging with positron emission tomography
Open Access
- 31 August 2006
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (12), 1720-1727
- https://doi.org/10.1016/j.ejca.2006.02.021
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- The contribution of PET/CT to improved patient managementThe British Journal of Radiology, 2006
- The uptake of 3?-deoxy-3?-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levelsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Assessment of Pharmacodynamic Vascular Response in a Phase I Trial of Combretastatin A4 PhosphateJournal of Clinical Oncology, 2003
- Positron Emission Tomography in Urologic OncologyCancer Control, 2002
- Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in CarcinogenesisJournal of Biological Chemistry, 2002
- Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug actionThe Lancet, 2000
- Positron emission tomography scanning in the evaluation of hepatocellular carcinomaJournal of Hepatology, 2000
- In vivo monitoring of drugs using radiotracer techniquesAdvanced Drug Delivery Reviews, 2000
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: A feasibility studyCancer Chemotherapy and Pharmacology, 1998